Literature DB >> 32620044

Effect and efficacy of lifestyle interventions as secondary prevention.

Jacob Liljehult1,2,3, Thomas Christensen1,4, Stig Molsted5, Dorthe Overgaard3, Monique Mesot Liljehult1, Tom Møller2,6.   

Abstract

INTRODUCTION: Improvements in health behaviour are often recommended as part of secondary prevention in patients with stroke and transient ischaemic attack. However, there is a lack of knowledge as to how this is applied in clinical practice. AIM: In this systematic review and meta-analysis, we examined the effect of counselling or educational intervention directed at individual or multiple behavioural risk factors on blood pressure and other reported outcomes.
METHODS: PubMed, Embase, PsycInfo, CINAHL, Scopus and Web of Science were systematically searched. Meta-analyses were conducted on all outcome measures if appropriate. A qualitative analysis of the content of the interventions was conducted to review which elements the interventions consisted of.
RESULTS: Twenty-nine randomized controlled trials were identified. Fourteen reported effects on systolic blood pressure, and pooled results showed a significant beneficial effect (n = 2,222; -3.85 mmHg [95%CI -6.43; -1.28]). The effect was greatest in the four interventions which included supervised training (n = 174; -9.83 mmHg [95%CI -16.56; -3.09]).
CONCLUSION: Modifying health behaviour in stroke survivors might have a moderate beneficial effect on blood pressure, especially if the intervention includes supervised physical training.
© 2020 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adherence; exercise; health behaviour; health counselling; physical activity; smoking; stroke; transient ischaemic attack

Mesh:

Year:  2020        PMID: 32620044      PMCID: PMC7540464          DOI: 10.1111/ane.13308

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


BACKGROUND

Stroke is one of the leading causes for morbidity, disability and death worldwide. The risk of recurrent stroke is 12%‐13% within the first year of the index stroke and 4%‐5% in the following year. Recurrent stroke is an independent risk factor for loss of function, institutionalization and death. Secondary and tertiary prevention are therefore important parts of stroke management. The pathological mechanisms behind vascular diseases are complex. It is evident that hypertension and other modifiable risk factors, such as smoking, physical inactivity, unhealthy diet and abdominal obesity, are all contributors to the risk of both ischaemic and haemorrhagic stroke. , Improved health behaviour is therefore widely recommended as part of the secondary prevention, yet our knowledge as to how these recommendations are applied effectively in clinical practice is sparse. The results of previous systematic reviews have been inconsistent. In a meta‐analysis of 42 randomized controlled trials (RCT) of stroke service‐based secondary prevention interventions, Bridgwood et al found no significant difference in any outcome measures, although there was a tendency towards a greater effect of organizational changes compared to educational/behavioural interventions. In a meta‐analysis of 20 RCTs of multi‐modal behavioural interventions, Lawrence et al found a significant effect on systolic and diastolic blood pressure, waist circumference, but not on blood lipids, blood glucose, body composition, smoking or fruit/vegetable consumption. In a meta‐analysis of 22 RCTs of lifestyle interventions in patients with stroke or transient ischaemic attacks (TIA), Deijle et al found a significant effect on systolic blood pressure, but not on diastolic blood pressure, cardiovascular events or blood lipids. A greater effect on systolic blood pressure was found in interventions which included aerobic exercise training and with a duration > 4 months. Most behavioural interventions are multi‐modal and complex. The varying results in previous studies might imply that some elements contribute more to the effect than others. We therefore need to examine the content of the interventions in order to identify the most effective approaches to behavioural change after stroke or TIA.

OBJECTIVES

The primary objective was to examine the effect of single‐ or multi‐modal counselling or educational intervention directed at individual or multiple lifestyle risk factors on blood pressure and hypertension in patients with stroke or TIA. The secondary objectives were to examine the effects on other outcomes, including recurrence of stroke and TIA, biochemistry, and health behaviour, and to examine the content and methodology of previous interventional studies.

METHODS

A systematic review of RCTs of counselling and educational interventions with stroke patients was conducted in accordance with the PRISMA statement.

Search method and eligibility criteria

Database searches were made in PubMed, Embase, PsycInfo, CINAHL, Scopus and Web of Science (see Figure 1); citations in previous articles were screened for relevant references. The search strategy was designed in collaboration with an experienced research librarian. Studies were included if they were RCTs of counselling or educational interventions (individual or group) targeting single or multiple lifestyle risk factors in hospital, outpatient or community settings, including adult (≥18 years) patients with first or recurrent stroke or TIA. The primary outcome of interest was systolic blood pressure; secondary outcomes included stroke recurrence, vascular events, mortality, physiological outcomes (eg blood pressure, blood lipids, body composition), health behaviour (eg smoking habits, alcohol consumption, diet, physical activity) or patient‐reported outcomes.
FIGURE 1

Search strategy and selection of reports

Search strategy and selection of reports Studies were excluded if they were not randomized and if the intervention was a pharmacological treatment (eg nicotine replacement) or focused on neurological rehabilitation of physical function or everyday activity. Titles were screened, and duplicates and non‐original publications (reviews, editorials, guidelines etc) were excluded by JL. Titles and abstracts were assessed by JL in the remaining references excluding studies that clearly included patients without cerebrovascular diseases, if the intervention was not relevant, if the design was non‐randomized, or no relevant outcomes were reported. In case information in the abstract was insufficient for exclusion the full text article was assessed. Full‐text assessment was performed by three reviewers independently (JL, MML, TM), and discrepancies were discussed until consensus was achieved. Data extraction was done by two reviewers independently using a standardized extraction form. Extracted data included details of the study design, population, intervention (timing, setting, procedures, dosage, mode of delivery), comparator intervention and relevant outcomes. Methodological quality and risk of bias were assessed by two reviewers independently using the Cochrane Risk of Bias tool (RoB), and discrepancies were resolved by discussion. If agreement was not meet, a third reviewer was consulted.

Qualitative analysis of the content of the intervention

A qualitative analysis of the reported interventions was conducted with the aim of gaining an overview of how the interventions attempted to modify the behaviour of the participants. Relevant parts of the articles, explaining the procedures of the interventions, were evaluated line by line and coded with explanatory expressions. Summaries of the interventions were constructed based on the codes, simple enough to give an overview but with enough details to be loyal to the original reports. The summaries were used to identify the main elements of the approaches and the targets of the intervention. Each element of the intervention was categorized using the World Health Organization's ICF‐model as a framework, categorizing the elements according to body function & anatomy, activity, participation, personal factors and environmental factors.

Quantitative meta‐analyses

Meta‐analyses were performed to estimate the overall treatment effect on all outcome measures reported in a comparable manner in at least two studies using Review Manager 5.3. As a result of variance in study populations, we used random effects models in all meta‐analyses. For continuous variables, we used mean differences if all studies reported the same scale of measurement; or standardized mean difference if the studies reported the same outcome with different measures or scales. For dichotomous variables, we used the Mantel‐Haenszel method for the risk ratios with 95% CI. All tests were two‐sided, and P‐values < .05 were considered statistically significant. Subgroup analyses were based on standardized mean differences in systolic blood pressure as it was the most commonly reported outcome measure. Kendall's rank correlation coefficient (Kendall's tau) was used to quantify the associations between study characteristics and standardized mean differences and completion rates, respectively.

RESULTS

We identified 10 052 records through database searches and additionally 42 through citations in previous systematic reviews. , , Of the 10 094 records, 4127 were duplicates, 825 were reviews, and 149 were other publication types (eg guidelines or editorials). The remaining 4993 records were screened for eligibility based on title and abstract, and 4864 records were excluded. All 129 remaining records were full text assessed by JL, MML and TM, and inclusion/exclusion was based on agreement between all three authors. Ultimately, 29 studies were included in the review (Figure 1 and Table 1).
TABLE 1

Characteristics of the study participants

Number of participants
Study (Country)ScreenedEligibleRandomizedCompletedAge (y)Female (%)Included diagnosesPrimary inclusion criteria
Adie 2010 (UK) 36 NA NA 565672.5 ± 8.950%TIA (43%)/minor stroke (57%)Age ≥ 18 y, hypertension, living at home
Allen 2002 (USA) 20 417238937370.5 ± 11.056%IS (70.5%), TIA (29.5%)Admitted from home, Rankin scale ≤ 3
Allen 2009 (USA) 37 NA NA 38031965 ± 14.350%IS (NIHSS ≥ 1)Discharge to home
Barker‐Collo 2015 (NZ) 21 3487 NA 386331 NA NA Stroke (not specified) Age ≥ 16 y
Boss 2014 (NL) 38 NA NA 201863 y (range 46‐78)30%TIA (40%), minor stroke (60%) (NIHSS < 4)Age ≥ 18 y, able to walk independently
Boysen 2009 (DK) 39 2000 NA 31427669.7 y (IQR 60‐78)44%ISAge ≥ 40 y, able to walk unassisted
Brunner Frandsen 2012 (DK) 40 NA NA 948853% 50‐65 y/ 26% >65 y42%IS & TIAAge < 76 y, current daily smoker
Chanruengvanich 2006 (TH) 41 NA NA 726263 ± 7.268%TIA & minor strokeAge > 45 y, able to exercise safely
Cheng 2018 (USA) 22 1476 NA 40440457.4 y40%IS & TIASBP ≥ 120 mmHg, English or Spanish speaker
Damush 2011 (USA) 23 1017 NA 636365.6 ± 10.52%ISAge ≥ 18 y, English speaker
English 2016 (AU) 42 NA 72333367.3 ± 13.033%IS (76%) & ICH (24%)Living at home
Evans‐Hudnall 2014 (USA) 43 210 NA 605253.0 ± 10.739%IS & TIAAge ≥ 18 y, discharged home
Faulkner 2014 (NZ) 24 16797605168.5 ± 10.448%TIA/minor strokeFirst ever TIA/stroke
Flemming 2013 (USA) 44 1083110413671 ± 11.041%Atherosclerotic IS (54%) & TIA (46%)Age ≥ 55 y, at least one uncontrolled risk factor
Gillham 2010 (UK) 25 91 NA 525068.3 ± 12.5 NA First time IS & TIAFirst time stroke/TIA
Holzemer 2011 (USA) 45 274 NA 522762.4 ± 12.0 NA IS & TIAAge ≥ 18 y
Hornnes 2009 (DK) 26 91747034930369.3 ± 12.949%IS, ICH, TIARelevant diagnosis
Irewall 2015 (SE) 27 1102 NA 53748470.8 ± 10.843%IS (60%), ICH (4%), TIA (37%)Able to participate
Joubert 2006 (AU) 28 421224978066.5 ± 13.750%IS, ICH, TIAAge ≥ 20 y, discharged to GP management
Joubert 2009 (AU) 46 NA NA 23318665.9 ± 13.445%IS, ICH, TIAAge ≥ 20 y, discharged to GP management
Kim 2013 (KR) 29 278 NA 363465.7 ± 7.536%ISLiving at home, access to the internet
Kirk 2014 (UK) 30 70 NA 242467.2 ± 9.421%Minor stroke (25%), TIA (75%)Fit for exercise
Kono 2013 (JP) 31 159134706863.5 ± 9.431%Minor stroke (non‐cardioembolic)Discharged home, mRS 0‐1
McManus 2009 (UK) 47 1804 NA 20510265.1 ± 9.348%Stroke (63%), TIA (27%), amaurosis fugax (4%), TGA (1%), RAO (2%), MID (3%)At least one relevant risk factor
Moren 2016 (SE) 32 127 NA 885671.1 ± 8.753%TIAMedically stable, able to communicate in Swedish
Nir 2004 (IL) 48 NA NA 155 NA 73.1 ± 7.348%Stroke (not specified) Relevant diagnosis
Peng 2014 (CN) 49 NA NA 3821333060.9 ± 11.632%IS & TIAAge ≥ 18 y, clinically stable, habitually independent in ADL
Wan 2016 (CN) 33 186103918059.7 ± 12.429%ISAge > 35 y, habitually independent in ADL
Wolfe 2010 (UK) 34 941 NA 52348721% >80 y47%IS (85.7%)Registered with a study GP

Abbreviations: ADL, Activity of Daily Living; GP, General practitioner; ICH, Intracerebral haemorrhage; IS, Ischaemic stroke; MID, Multi‐Infarct Disease; mRS, Modified Rankin Scale; NIHSS, NIH Stroke Scale; RAO, Retinal Artery Occlusion; TIA, Transient Ischaemic Attacks.

Characteristics of the study participants Abbreviations: ADL, Activity of Daily Living; GP, General practitioner; ICH, Intracerebral haemorrhage; IS, Ischaemic stroke; MID, Multi‐Infarct Disease; mRS, Modified Rankin Scale; NIHSS, NIH Stroke Scale; RAO, Retinal Artery Occlusion; TIA, Transient Ischaemic Attacks.

Description of the studies

Targets of the intervention

Table 2 provides an overview of study rationales and contents of the interventions. In 16 studies, the aim was to enable the participants to take care of their own health, for example facilitate modification of lifestyle factors or adherence to preventive medication. In eight studies, the primary aim was to increase the participants’ level of physical activity, and in additionally four studies physical activity was a minor part of the counselling. Four studies included supervised strength and aerobic exercise. Studies including physical activity also included other elements, such as patient education or health counselling (Table 2).
TABLE 2

Content of the interventions

Targets of the intervention
Looking after one's health (16 studies)
Modification of behaviour, such as smoking, alcohol use, diet, or adherence to medication 24 , 25 , 26 , 30 , 31 , 33 , 34 , 36 , 40 , 41 , 43 , 44 , 45 , 47 , 48 , 49
Physical activity
Counselling in physical activity (8 studies) 24 , 30 , 31 , 32 , 38 , 39 , 41 , 42
Supervised training (aerobic and strength training) (4 studies) 24 , 30 , 31 , 38
Managing stress & anxiety (5 studies) 23 , 24 , 30 , 41 , 43
Activities of daily living (2 studies)
Planning or training of everyday activities 23 , 48
Knowledge about stroke and health
Knowledge about stroke, risk factors, lifestyle, or medication (21 studies) 20 , 22 , 23 , 24 , 25 , 26 , 29 , 30 , 31 , 34 , 36 , 37 , 39 , 41 , 43 , 44 , 45 , 46 , 47 , 49
Increasing cognitive skills, such as motivation and self‐management (10 studies) 21 , 22 , 23 , 24 , 25 , 32 , 33 , 36 , 42 , 44
Specific skills such as goal setting or planning behaviour (7 studies) 23 , 33 , 41 , 42 , 43 , 44 , 48
Approaches of the intervention
Communicating knowledge
Written material (4 studies) 36 , 43 , 45 , 47
Computer‐based patient education (4 studies) 29 , 31 , 34 , 49
Patient education/group education (12 studies) 22 , 24 , 25 , 29 , 30 , 31 , 37 , 41 , 44 , 46 , 47 , 49
Counselling
Counselling in health behaviour and behavioural change (20 studies 22 , 26 , 27 , 31 , 33 , 38 , 39 , 40 , 47 , 49 ; of which 10 studies used a specific technic or theoretical framework 21 , 23 , 25 , 32 , 36 , 41 , 42 , 43 , 45 , 48 )
Medication
Nicotine substitution (1 study) 40
Self‐monitoring
Monitoring of behaviour, physical activity, blood pressure (4 studies) 22 , 26 , 41 , 42
Evaluation of needs
Evaluation of the participants’ needs (6 studies) 20 , 27 , 28 , 37 , 46 , 48
Support
Professional support (22 studies) 20 , 21 , 22 , 23 , 25 , 27 , 28 , 32 , 33 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48
Peer support from other patients (4 studies) 22 , 23 , 24 , 38
Social support from family, friends or relatives (6 studies) 20 , 37 , 41 , 43 , 46 , 48
Content of the interventions Counselling on anxiety or stress management was included in five studies, and two studies included counselling on participation in everyday life. Twenty‐one studies aimed at providing participants with knowledge on their disease, lifestyle and vascular risk factors, or preventive medication. Nine studies aimed at providing participants with the cognitive skills and know how to modify their health behaviour, such as motivation, self‐efficacy or self‐management skills, while seven studies aimed at providing specific behavioural skills, such as self‐monitoring, goal setting and planning behavioural change.

Approaches of the interventions

Of the 21 studies, which included communication of knowledge, twelve included direct patient education, of which two were provided in a group setting. Four studies employed written educational material and four employed computer‐based education. Patient counselling was part of the invention in twenty of the studies, and in ten of them, the counselling was based in a specific technic or theoretical framework. Most of them employed face‐to‐face counselling the first time, while the following sessions were provided either face‐to‐face or by telephone. Only one study provided nicotine substitution as a medical aid for smoking cessation. Four studies used self‐monitoring; either of physical activity, behaviour or blood pressure as a part of the intervention. Additionally, six studies had a regular assessment of the participants need for assistance or help. Systematic support in relation to behavioural change or handling own health was a part of the intervention in 23 of the studies. In 22 of the studies, the support was provided by health professionals affiliated with the intervention team, in some cases in addition to other types of support, and in a single study, the support was provided by the participants’ primary physician. Four studies employed group elements or activities to facilitate peer support from other participants, and in six studies, the participants’ own social network was used as support, either by directly including the relatives in activities or by encouraging participants to seek support from friends and relatives. In nine studies, the intervention or part of the intervention comprised changes to the organization of the care, for example home visits, implementation of clinical guidelines, or changes in the communication or collaboration between the hospital and the primary physicians.

Time of recruitment and length of intervention

In eight studies, participants were recruited before hospital discharge; in ten studies, they were recruited within the first month; and in seven studies, they were recruited between 1‐12 months after admission. In four studies, the time of recruitment was not reported (Table 3).
TABLE 3

Characteristics of the interventions

Study (Country)Time of recruitmentLength of interventionTime of follow‐upMain elements of the interventionTheoretical frameworkTargets
Adie 2010 (UK)<1 mo4 mo6 moIndividual counselling; written educational material; telephone follow‐upSocial‐cognitive theoryMedication, blood pressure, lipids, smoking, diet, exercise
Allen 2002 (USA)Before discharge3 mo3 moHome visits; evaluation of need for care and support; plan for primary physicianHealth, psycho social well‐being
Allen 2009 (USA)Before discharge6 mo6 moHome visits; evaluation of need for rehabilitation, care and support; plan for primary physicianThe chronic illness model
Barker‐Collo 2015 (NZ)28 d9 mo12 moIndividual counselling; support in goal setting; telephone follow‐upMotivational interviewing
Boss 2014 (NL)<1 wk8 wk6 + 12 moSupervised exercise; individual counsellingMotivational interviewingPhysical activity
Boysen 2009 (DK)<90 d24 mo24 moIndividual counselling; repeated encouragement for physical activity; inpatient follow‐upPhysical activity
Brunner Frandsen 2012 (DK) Unclear 4 mo6 moIndividual counselling; telephone follow‐up; nicotine substitutionSmoking
Chanruengvanich 2006 (TH) Unclear 12 wk12 wkIndividual counselling; patient education; self‐regulation training; home visits; telephone follow‐upSelf‐regulation theory (Bandura, Pender)Stroke knowledge, diet, weight, stress management
Cheng 2018 (USA)<90 d12 mo12 moGroup & individual counselling; telephone follow‐up; blood pressure monitoringThe chronic care modelBlood pressure, medication adherence, smoking, physical activity, depression
Damush 2011 (USA)<1 mo12 wk6 moPatient education; individual counselling in goal setting; telephone or face‐to‐face follow‐upSelf‐efficacy theory (Bandura)Risk factor management
English 2016 (AU)>6 mo7 wk7 wkIndividual counselling; monitoring of physical activity; telephone follow‐upMotivational interviewingPhysical activity
Evans‐Hudnall 2014 (USA)Before discharge4 wk4 wkIndividual counselling; training in self‐management skills; written material; out‐patient follow‐upRisk factor management
Faulkner 2014 (NZ)<2 wk8 wk12 moSupervised exercise; individual counselling; patient education; group exerciseThe health belief modelVascular risk factor control, diet, blood pressure, medication adherence, stress management
Flemming 2013 (USA)<12 wk1 y1 yPatient education; individual counselling; summary to the primary physician; out‐patient and telephone follow‐upMotivational interviewingDiet, exercise
Gillham 2010 (UK) Unclear 3 mo3 moIndividual counselling; patient education; face‐to‐face or telephone follow‐upMotivational interviewing, the transtheoretical modelRisk factor control
Holzemer 2011 (USA)Before discharge3 wk3 moIndividual counselling; face‐to‐face and telephone follow‐upSelf‐determination theorySmoking, diet, exercise, stroke knowledge, medication
Hornnes 2009 (DK) Unclear 10 mo1 yHome visits; individual counselling; monitoring of blood pressureMedication adherence, lifestyle factors
Irewall 2015 (SE)1 mo after discharge12 mo12 moIndividual counselling; evaluation of preventive treatment; telephone follow‐upMedication, lifestyle factors
Joubert 2006 (AU)Before discharge12 mo12 moShared care between hospital and primary physician; regular outpatient follow‐up; telephone remindersPhysical activity, smoking, alcohol, medication, depression, blood pressure, lipids, risk factors
Joubert 2009 (AU)Before discharge12 mo12 moShared care between hospital and primary physician; regular outpatient follow‐up; telephone remindersPhysical activity, smoking, alcohol, medication, depression, blood pressure, lipids, risk factors
Kim 2013 (KR)1‐12 mo9 wk3 moWeb‐based patient education
Kirk 2014 (UK)<1 mo6 wk6 moSupervised exercise; group educationPhysical activity, medication, alcohol, exercise, diet, stroke knowledge, well being
Kono 2013 (JP)Before discharge24 wk3.3 ySupervised exercise; computer‐based patient educationExercise, salt intake
McManus 2009 (UK)<3 mo3 mo3.6 yIndividual counselling; written material; patient education; out‐patient follow‐upLifestyle, medication, stroke knowledge
Moren 2016 (SE)<2 wkUnclear6 moIndividual counselling; exercise prescription; outpatient follow‐upMotivational interviewingPhysical activity
Nir 2004 (IL)<13 d12 wk3 + 6 moIndividual counselling; evaluation of self‐care agency; regular home visitsThe self‐care model (Orem)Self‐care (incl. lifestyle management)
Peng 2014 (CN)<30 dUnclear12 moImplementation of standard guidelines; individual counselling; web‐based patient educationSmoking, diet, exercise, stroke knowledge
Wan 2016 (CN)Before discharge3 mo6 moIndividual counselling; training of self‐management skills; telephone follow‐upSelf‐management, health behaviour
Wolfe 2010 (UK)<6 mo6 mo12 moAlgorithm‐based prevention plan sent by mail; enhanced corporation with the primary physician
Characteristics of the interventions The length of the interventions varied between three weeks and two years, with seven studies in each interval of 3‐12 weeks, 12‐13 weeks, 13‐52 weeks and ≥ 52 weeks. One study did not report the length of the intervention (Table 3).

Risk of bias in included studies

Random allocation of participants was an inclusion criterium in this review, and all studies therefore stated that they were RCTs. In 25 of the studies, the method of randomization was clearly reported, but in three studies this was unclear, and in one study, the method was not adequately described. In 19 studies, measures to conceal future allocations were clearly stated; in nine studies, it was unclear, and in one study, measures were inadequate. None of the studies had adequate blinding of participants and personal delivering the intervention; although one study used “placebo” counselling, it was unclear if this blinding was effective as the personnel was not blinded. In 13 studies, the outcome assessments were adequately blinded, but in the remaining studies outcome measurements were performed by unblinded study personal. In 22 of the studies outcome, data were either complete or the incompleteness was clearly accounted for. In four studies, the completeness of data was unclear, and in three studies, outcome data were clearly missing and not adequately accounted for. In 24 of the studies, results of all outcome measures were clearly reported; in four studies, the results were not clearly reported in the secondary outcomes measures, and in one study, the results were reported in an ambiguous and unclear manner. Other potential biases were found: Five studies had baseline imbalances of potential clinical importance; two studies were stopped early without a clear reason stated; and several studies used block randomization with fixed block sizes potentially resulting in study personal being able to foresee the allocation of some participants before recruitment (Figure 2).
FIGURE 2

Risk of bias summary: the authors' judge‐ments about each risk of bias item for each included study

Risk of bias summary: the authors' judge‐ments about each risk of bias item for each included study

Effects of interventions

The most frequent outcome reported were systolic and diastolic blood pressure, which were both significantly lower among participants in the interventions (Tables 4 and 5, Figure 3). Six studies reported the number of participants with a systolic blood pressure < 140 mmHg at follow‐up. In a random effects model, the pooled risk ratio was 1.14 (95%CI 1.03‐1.25), equivalent to a number needed to benefit of 13.83 (95%CI 8.25‐42.84) (Table 5, Figure 3).
TABLE 4

Outcomes reported in each study as either primary, secondary, or part of a compound outcome measure

Adie 2010Allen 2002Allen 2009Barker‐Collo 2015Boss 2014Boysen 2009Brunner Frandsen 2012Chanruengvanich 2006Cheng 2018Damush 2011English 2016Evans‐Hudnall 2014Faulkner 2014Flemming 2013Gillham 2010Holzemer 2011Hornnes 2009Irewall 2015Joubert 2006Joubert 2009Kim 2013Kirk 2014Kono 2013McManus 2009Moren 2016Nir 2004Peng 2014Wan 2016Wolfe 2010
Vital signs112211221121222
Biochemistry212222222222222
Body composition222222
Adverse eventscc121122
Function2cc212222
Medication adherence222c222222
Patient activation2c21222222
PROM2cc22122222222
Risk factorscc2122112122221212111
Physical activity21221

1: Primary outcome, 2: secondary/tertiary outcomes, c: part of a composite outcome, PROM Patient Reported Outcome Measure.

TABLE 5

Results of the meta‐analyses

OutcomesStudiesParticipantsEffect Estimate P‐value I 2 Quality of evidence (GRADE)
Vital signs
Systolic blood pressure (mmHg) 21 , 22 , 24 , 26 , 27 , 28 , 30 , 31 , 36 , 38 , 41 , 45 , 46 , 47 142222MD −3.85 [−6.43, −1.28].003** 53%⊕⊕◯◯ LowA, B
Diastolic blood pressure (mmHg) 21 , 24 , 26 , 27 , 30 , 31 , 36 , 38 , 41 , 45 , 46 , 47 121711MD −1.60 [−3.09, −0.11].04* 40%⊕⊕◯◯ LowA, B
SBP < 140 mmHg 22 , 27 , 28 , 37 , 38 , 46 61546RR 1.14 [1.03, 1.25].01** 23%⊕⊕◯◯ LowA, B
Heart rate (Beats per minute) 24 , 41 2113MD −2.87 [−6.34, 0.61].110%⊕◯◯◯ Very lowA, B, C
Biochemistry
Total cholesterol 21 , 24 , 28 , 29 , 30 , 36 , 41 , 45 , 46 , 47 10925MD −4.25 [−9.27, 1.22].139%⊕⊕◯◯ LowA, B
HDL 21 , 24 , 30 , 31 , 41 , 45 6552MD 1.64 [−1.12, 4.40].240%⊕⊕◯◯ LowA, B
LDL 22 , 27 , 31 , 38 , 45 51003SMD −0.23 [−0.41, −0.05].01** 36%⊕⊕◯◯ LowA, B
Triglycerides 29 , 45 263MD −14.71 [−43.07, 13.56].310%⊕◯◯◯ Very lowA, B, C
Fasting blood glucose 24 , 30 275MD −0.19 [−0.47, 0.10].200%⊕◯◯◯ Very lowA, B, C
HbA1c 31 , 47 2170MD 0.12 [−0.46, 0.70].6963%⊕◯◯◯ Very lowA, B, C
TC/HDL‐ratio 24 , 30 275MD 0.0 [−0.49, 0.49].990%⊕◯◯◯ Very lowA, B, C
Body composition
Body mass index 24 , 30 , 31 , 46 4329MD −0.44 [−1.38, 0.51].370%⊕◯◯◯ Very lowA, B, C
Body weight 24 , 31 , 36 , 44 4175MD −0.53 [−4.09, 3.03].770%⊕◯◯◯ Very lowA, B, C
Waist‐hip ratio 24 , 30 275MD 0.0 [−0.04, 0.03].830%⊕◯◯◯ Very lowA, B, C
Adverse events
Death (All causes) 20 , 24 , 37 , 39 , 49 54668RR 0.97 [0.58, 1.61].370%⊕⊕◯◯ LowA, B
Recurrent stroke/TIA 20 , 39 , 47 , 49 44330RR 1.08 [0.78, 1.50].770%⊕⊕◯◯ LowA, B
Adverse events (All) 20 , 31 , 37 , 39 , 42 , 47 , 49 74813RR 0.77 [0.56, 1.08].830%⊕⊕◯◯ LowA, B
Functional level
Modified Rankin scale 33 , 36 , 39 , 46 4606SMD −0.26 [−0.58, 0.05].1169%⊕◯◯◯ Very lowA, B, C
Patient reported outcomes
Quality of life 21 , 23 , 30 , 46 , 47 61546SMD −0.09 [−0.53, 0.34].6785%⊕◯◯◯ Very lowA, B, D

All meta‐analyses are based on random effects models. Mean difference (MD) was used for parametrical outcomes when all studies reported the same unit; standardized mean difference (SMD) was used for parametrical outcomes when different units were reported; risk ratio (RR) was used for binominal outcome measures.

Abbreviations: HDL, High‐density Lipoprotein; LDL, Low‐density lipoprotein; MD, Mean difference; RR, Risk ratio; SBP, Systolic blood pressure; SMD, Standardized Mean Difference; TC/HDL ratio, Total cholesterol/HDL ratio.

P < .05,

P < .01,

P‐value for the overall effect of the model. GRADE [50]: A, Down‐graded due to insufficient blinding, B, Down‐graded due to indirectness caused by substantial different intervention, C, Down‐graded because the analysis is based on limited data (few studies or few participants), D, Down‐graded due to the use of indirect outcome measures.

FIGURE 3

Forest plots (Only statistically significant analyses are shown)

Outcomes reported in each study as either primary, secondary, or part of a compound outcome measure 1: Primary outcome, 2: secondary/tertiary outcomes, c: part of a composite outcome, PROM Patient Reported Outcome Measure. Results of the meta‐analyses All meta‐analyses are based on random effects models. Mean difference (MD) was used for parametrical outcomes when all studies reported the same unit; standardized mean difference (SMD) was used for parametrical outcomes when different units were reported; risk ratio (RR) was used for binominal outcome measures. Abbreviations: HDL, High‐density Lipoprotein; LDL, Low‐density lipoprotein; MD, Mean difference; RR, Risk ratio; SBP, Systolic blood pressure; SMD, Standardized Mean Difference; TC/HDL ratio, Total cholesterol/HDL ratio. P < .05, P < .01, P‐value for the overall effect of the model. GRADE [50]: A, Down‐graded due to insufficient blinding, B, Down‐graded due to indirectness caused by substantial different intervention, C, Down‐graded because the analysis is based on limited data (few studies or few participants), D, Down‐graded due to the use of indirect outcome measures. Forest plots (Only statistically significant analyses are shown) Sub‐analyses of the studies reporting systolic blood pressure showed that both interventions with and without supervised physical training had a significant effect, but the effect was greater in interventions including supervised training (9.4 (95%CI 3.1‐16.6) vs. 2.6 (95%CI 1.0‐4.3) mmHg). The inter‐strata differences were not significant for time of recruitment, length of the intervention, intervention based on a specific theoretical framework or family support (Table 5).

Feasibility

The number of potential participants screened for eligibility was reported in 20 studies; of 16,227 screened, 3545 were included for participation. The inclusion rates ranged from 3.8%‐69.3% with a weighted mean of 22% (95%CI 21.2‐22.5). The rate of inclusion from the number of patients eligible for participation was reported in eight studies; out of 1448 eligible patients, 836 were included for participation. Inclusion rates ranged from 37.3%‐88.3% with a weighted mean of 58% (95%CI 55.2‐60.3). Completion rates of participants were reported in 28 studies. Of 8254 participants randomized, 7173 were retained until the final follow‐up. Completion rates ranged from 49.8%‐100% with a weighted mean of 86.9% (95%CI 86.2‐87.6). Five studies achieved a completion rate of 100% (Table 1). There was a significant correlation between completion rate and the timing of recruitment (tau = 0.377; P = .018), an indication of a more complete follow‐up in studies with late recruitment. No significant correlation was found between completion rate and the length of the intervention (Kendall's tau = −0.07; P = .63) or time of follow‐up (Kendall's tau = −0.08; P = .59), respectively.

DISCUSSION

In this systematic review, we have explored the effects of health behaviour counselling and behavioural modification in patients with cerebrovascular diseases, and potential mediators of the effects. We found that, although the effect sizes are modest, supportive behavioural interventions might have some additional effect on systolic and diastolic blood pressure, the prevalence of hypertension and low‐density lipoprotein in the blood compared to usual care. Including supervised exercise as part of the intervention seems to enhance the effect on systolic blood pressure. Besides that, we did not find any intervention elements capable of mediating the effectiveness. Interventions were applied as add‐on to usual care though the exact definitions and components of usual care seldom were elucidated. Consequently, we are not able to determine the causal mechanism and effects related to the intervention as the effect on, for example systolic blood pressure might have been mediated by enhanced adherence to medication rather than an isolated interventional effect. We identified a range of different intervention element, which might all contribute to the overall effect of the interventions, but only blood pressure and total blood cholesterol were reported in ≥ 10 studies, and the lack of uniformly reported outcomes made it difficult to compare the effectiveness of the elements. The inclusion and completion rates varied considerably between studies. Approximately half of eligible patients consented to participation, and the rate of successful follow‐up ranged from 50%‐100%. We found some association between the timing of recruitment and the completion rates, implying that participants are more likely to leave the study if they are recruited early. A reason for this might be that studies with late recruitment primarily approached patients in outpatient clinics, hence including patients who are more motivated to participate in additional treatment, if offered. In contrast, the time of recruitment did not seem to impact the effect of the intervention. Recruiting participants at an early stage is therefore feasible, but a higher rate of attrition should be expected. Previous systematic reviews of behavioural interventions in patients with stroke have arrived at different conclusions. Deijle et al found an effect on systolic blood pressure; Lawrence et al found an effect on waist circumference, compliance to preventive medication, anxiety, cardiac events, and systolic and diastolic blood pressure, while Bridgwood et al found no effect of behavioural interventions, but minor effects on TIA recurrence and cardiovascular risk scores in organizational changes. Different statistical approaches might explain the varying results: Lawrence et al used fixed effect models, assuming that “all studies were functionally identical,” whereas Bridgwood et al used random effects models and Deijle et al different models depending on the degree of heterogeneity. We used random effects models in all our meta‐analyses, assuming that clinical diversity in study populations, settings and interventions contributed to variation between studies, and therefore, we did not find the assumptions of a fixed effect model to be justified. In a systematic review of qualitative interviews with participants in secondary stroke prevention interventions and their family members, Lawrence et al found that the participants experienced the interventions as meaningful. The informants highlighted the importance of support from health professionals, family and other stroke survivors, and that the interventions helped them acquire the knowledge and confidence needed to change behaviour. Several interventions incorporated formal support from health professionals and informal support from peers and the participants’ family and social network; patient education or other means of communicating knowledge; or counselling in goal setting, planning and confidence to change behaviour. Although the formal effects of the behavioural interventions might be vague, they could be meaningful and beneficial to the patients. Cognitive difficulties and fatigue are prevalent, even among patients with minor stroke and for some having a stroke can be a considerable change in their life. Health behaviour is regulated by a multitude of biological, psychological and social factors. Interventions to modify patient behaviour are therefore complex in nature. At this point, we are not able to recommend any specific approach to behavioural modification. The evidence supports that the interventions should include physical exercise. Previous research indicates that behavioural interventions should address several domains and have multiple points of follow‐up over at least a month. , Several potential biases were identified in the included studies. All included studies were randomized, and most of them reported the procedure of randomization and measures to conceal the allocation of future participants. Blinding measure such as assessor blinding was only reported in less than half of the studies. Furthermore, the use of self‐reported outcome measures might be sensitive to rapport between the participant and the assessor. In five studies, the results were reported in an inadequate manner: one study only reported results from a model adjusted for baseline imbalances. The remaining four lacked necessary details, for example. standard deviations, confidence intervals or exact p‐values. Such inaccuracies made it difficult to assess the risk of selective reporting. To assess the risk of publication bias, we attempted to match preliminary reports to subsequent full‐text publications. We identified 23 conference proceedings, 18 study protocols and one academic thesis that were potentially relevant. Of these records, 10 did not fulfil all inclusion criteria and 20 were matched to publications already included in the search results. Of the remaining 12 reports, we managed to find trial registrations on 10 studies. This might indicate that there is a risk of publication bias, although this was less than observed in other research areas. Generalizability of the results might be limited by selection bias. The number of patients screened for eligibility was reported in 19 studies, and the number of eligible patients was reported in nine studies (Table 1). The number of refusals was reported in 15 studies , , , , , , , , , , , , , , with proportions ranging from 0.6%‐66.7% (median 36.8%). Only two studies , reported reasons for refusal (eg lack of time, work commitments, transportation problems, lack of interest). Although this review was designed to be comprehensive, there is still a risk that relevant research was not included. We searched several different medical databases and searched references of previous studies, and we attempted to find full publications of preliminary reports. Due to language restrains, we could only include literature in English and Scandinavian languages. We only included study results as they were reported in the full‐text articles or supplementary materialsupplementary material. But we did not attempt to obtain the original datasets or any missing data.

CONCLUSIONS

Interventions to modify health behaviour in patients with stroke and prevent stroke recurrence might have a modest effect; but may still be meaningful to the patient. Recruiting patients at an early stage after stroke does not seem to affect the effect, but a higher attrition rate should be expected. Supervised exercise most likely enhances the effect of the interventions on blood pressure. However, we need further research on how other approaches, including health counselling, support from professionals, relatives, or peers, patient education, monitoring of behaviour and health status, and primary and secondary sector collaboration, could benefit the patients and their relatives.

CONFLICTS OF INTERESTS

The authors declare no conflicts of interests.

AUTHORS CONTRIBUTIONS

All contributors eligible for authorship are listed as authors according to the Danish Code of Conduct for Research Integrity. JL designed the study and wrote the protocol in collaboration with TM, TC, SM, DO; JL performed the literature search; Study selection was performed by JL, TM, MML; Analysis was performed by JL; All authors participated in the assessment of quality and risk of bias, data extraction, and writing the report. Supinfo Click here for additional data file.
  42 in total

1.  Risk factor management and depression post-stroke: the value of an integrated model of care.

Authors:  Jacques Joubert; Chris Reid; Lynette Joubert; David Barton; Denise Ruth; David Jackson; John O' Sullivan; Stephen M Davis
Journal:  J Clin Neurosci       Date:  2006-01       Impact factor: 1.961

2.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Walter N Kernan; Bruce Ovbiagele; Henry R Black; Dawn M Bravata; Marc I Chimowitz; Michael D Ezekowitz; Margaret C Fang; Marc Fisher; Karen L Furie; Donald V Heck; S Claiborne Clay Johnston; Scott E Kasner; Steven J Kittner; Pamela H Mitchell; Michael W Rich; DeJuran Richardson; Lee H Schwamm; John A Wilson
Journal:  Stroke       Date:  2014-05-01       Impact factor: 7.914

3.  The Effects of "Physical Activity on Prescription" in Persons With Transient Ischemic Attack: A Randomized Controlled Study.

Authors:  Carina Morén; Anna-Karin Welmer; Maria Hagströmer; Emelie Karlsson; Disa K Sommerfeld
Journal:  J Neurol Phys Ther       Date:  2016-07       Impact factor: 3.649

4.  Improving secondary stroke self-care among underserved ethnic minority individuals: a randomized clinical trial of a pilot intervention.

Authors:  Gina L Evans-Hudnall; Melinda A Stanley; Allison N Clark; Amber L Bush; Ken Resnicow; Yu Liu; Joseph S Kass; Angelle M Sander
Journal:  J Behav Med       Date:  2012-12-08

5.  Does behaviour modification affect post-stroke risk factor control? Three-year follow-up of a randomized controlled trial.

Authors:  Julie Ann McManus; Alison Craig; Christine McAlpine; Peter Langhorne; Graham Ellis
Journal:  Clin Rehabil       Date:  2009-01-07       Impact factor: 3.477

6.  Effectiveness of Goal-Setting Telephone Follow-Up on Health Behaviors of Patients with Ischemic Stroke: A Randomized Controlled Trial.

Authors:  Li-Hong Wan; Xiao-Pei Zhang; Miao-Miao Mo; Xiao-Ni Xiong; Cui-Ling Ou; Li-Ming You; Shao-Xian Chen; Min Zhang
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-06-28       Impact factor: 2.136

7.  Utility of a post-hospitalization stroke prevention program managed by nurses.

Authors:  Kelly D Flemming; Thomas G Allison; Jody L Covalt; Debra E Herzig; Robert D Brown
Journal:  Hosp Pract (1995)       Date:  2013-08

Review 8.  Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke.

Authors:  Charles David Alexander Wolfe; Judith Redfern; Anthony George Rudd; Andrew Peter Grieve; Peter Ulrich Heuschmann; Christopher McKevitt
Journal:  Stroke       Date:  2010-09-23       Impact factor: 7.914

9.  Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors:  Valery L Feigin; Gregory A Roth; Mohsen Naghavi; Priya Parmar; Rita Krishnamurthi; Sumeet Chugh; George A Mensah; Bo Norrving; Ivy Shiue; Marie Ng; Kara Estep; Kelly Cercy; Christopher J L Murray; Mohammad H Forouzanfar
Journal:  Lancet Neurol       Date:  2016-06-09       Impact factor: 44.182

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  1 in total

1.  Effect and efficacy of lifestyle interventions as secondary prevention.

Authors:  Jacob Liljehult; Thomas Christensen; Stig Molsted; Dorthe Overgaard; Monique Mesot Liljehult; Tom Møller
Journal:  Acta Neurol Scand       Date:  2020-07-15       Impact factor: 3.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.